1.
Talamonti M, Malara G, Natalini Y, Bardazzi F, Conti A, Chiricozzi A, et al. Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis: A Post hoc Analysis of the SUPREME Study. Acta Derm Venereol [Internet]. 2021 Mar. 31 [cited 2024 Nov. 3];101(3):adv00422. Available from: https://medicaljournalssweden.se/actadv/article/view/973